OcuSciences
Manufacturing · Michigan, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
2890 Carpenter Rd Ste 1800, Ann Arbor, M...Phone Number
(734) 205-5854Website
www.ocusciences.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About OcuSciences
OcuSciences is a biotech startup based in Ann Arbor, MI, focused on developing ocular imagers to analyze oxidative stress for the detection and monitoring of eye diseases. Their flagship product, the OcuMet Beacon, utilizes advanced autofluorescence technology to provide rapid, non-invasive assessments of ocular health. The company aims to assist ophthalmologists and optometrists in diagnosing and managing eye conditions through innovative imaging solutions. OcuSciences is committed to enhancing the capabilities of eye care professionals with state-of-the-art devices.Explore more
OcuSciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is OcuSciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at OcuSciences
Check out if OcuSciences is spiking on competitors!
Product Launch: Get notified when OcuSciences launches new products
Earning: See what the market has to say on OcuSciences recently announced quarterly report
Click to see if OcuSciences had a recent Job posting/layoffs
OcuSciences, which may be a good buyer, showed buying intent in Masked Content Topic
Check if OcuSciences has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once OcuSciences has new funding data
Recommended Actions
Find VP level buyers at OcuSciences
Find more new buyers
Compare Similar Companies to OcuSciences
Compare insights from companies similar to OcuSciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
OcuSciences is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
OcuSciences is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about OcuSciences.
OcuSciences Tech Stack
A closer look at the technologies used by OcuSciences
See more technologies
OcuSciences News & Media
OcuSciences Announces FDA Marketing Clearance of OcuMet Beacon in Retinal Health Assessment at ARVO
ANN ARBOR, Mich.--(BUSINESS WIRE)--OcuSciences, Inc., a leader in advanced ocular diagnostics, today announced that the U.S. Food and Drug Administration (FDA) has granted clearance for its flagship device, the OcuMet Beacon, proprietary, non-invasive tool for assessing retinal health. The indication for use of the OcuMet Beacon is a confocal scanning ophthalmoscope indicated for infrared (IR) and autofluorescence (AF) imaging of a human retina with or without the use of a mydriatic agent. TheOcuSciences Welcomes Michael Patane, PhD, to its Board of Directors
ANN ARBOR, Mich.--(BUSINESS WIRE)--OcuSciences, a medical device company developing ocular imagers to detect early disease by assessing retinal metabolic activity, today announced the addition of Michael Patane, PhD, to its Board of Directors. Dr. Patane brings over 25 years of drug discovery and development experience, with a proven track record of leadership in startup, biotechnology and pharmaceutical companies. Many of these roles included ophthalmic product creation and development. Most rOcuSciences Announces Publication Showing Potential to Detect Retinal Diseases with High Sensitivity
ANN ARBOR, Mich.--(BUSINESS WIRE)--OcuSciences, a medical device company developing ocular imagers to detect early disease by assessing retinal metabolic activity, today announced a publication in Frontiers in Ophthalmology journal. By assessing the flavoprotein fluorescence in the retina with its flagship device, the OcuMet Beacon, these findings suggest that the novel FPF measure can detect retinal diseases with a high degree of sensitivity. This cross-sectional observational study, led by RiStudy Shows Novel Flavoprotein Fluorescence Measure is Correlated with Age-Related Macular Degeneration (AMD) Stage
ANN ARBOR, Mich.--(BUSINESS WIRE)--OcuSciences, a medical device company developing ocular imagers to detect early disease by assessing retinal metabolic activity, today announced the publication of an Age-related Macular Degeneration (AMD) study in the Ophthalmic Surgery, Lasers and Imaging Retina journal. By quantifying the degree of retinal oxidative stress and mitochondrial dysfunction, these findings suggest that the novel FPF measure can categorize AMD patients by stage, which may better
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding OcuSciences
Sign Up For FreeTo access detailed company insights
OcuSciences is a biotech startup based in Ann Arbor, MI, focused on developing ocular imagers to analyze oxidative stress for the detection and monitoring of eye diseases. Their flagship product, the OcuMet Beacon, utilizes advanced autofluorescence technology to provide rapid, non-invasive assessments of ocular health. The company aims to assist o... Read More
